Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Primary Purpose
Esophageal and Gastric Varices
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Esophageal Capsule Endoscopy
Upper Gastrointestinal Endoscopy
Sponsored by
About this trial
This is an interventional diagnostic trial for Esophageal and Gastric Varices focused on measuring Esophageal Varices, Gastric Varices, Capsule Endoscopy, Portal Hypertension, Cirrhosis, Gastrointestinal Hemorrhage
Eligibility Criteria
Inclusion Criteria:
- Advanced cirrhosis with portal hypertension based on imaging, clinical suspicion, or liver biopsy
- Age greater than or equal to 18 years old
- Able to give consent
Exclusion Criteria:
- Current implantable cardioverter-defibrillators or pacemaker in place
- Suspected intestinal obstruction
- Esophageal swallowing disorder
- Esophageal stenosis
- Age less than 18 years old
- Pregnancy
- Known Zenker's diverticulum
- Patients with previous endoscopic or surgical esophageal treatment
Sites / Locations
- Johns Hopkins Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Capsule Endoscopy
Upper Gastrointestinal Endoscopy
Arm Description
Outcomes
Primary Outcome Measures
The primary endpoint of the study will be to develop a grading system for esophageal varices using capsule endoscopy.
Secondary Outcome Measures
Secondary endpoints include sensitivity, specificity, inter- and intraobserver variation of variceal grading using capsule endoscopy; patient acceptance; and a cost comparison (facility + professional fees) of the two screening methods.
Full Information
NCT ID
NCT00475592
First Posted
May 16, 2007
Last Updated
July 20, 2017
Sponsor
Johns Hopkins University
Collaborators
Ethicon, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00475592
Brief Title
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Official Title
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Study Type
Interventional
2. Study Status
Record Verification Date
July 2017
Overall Recruitment Status
Withdrawn
Why Stopped
study failed to recruit
Study Start Date
January 2007 (Actual)
Primary Completion Date
May 2008 (Actual)
Study Completion Date
May 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
Ethicon, Inc.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to develop a grading system for esophageal varices using capsule endoscopy in patients with portal hypertension and cirrhosis.
Detailed Description
Up to 35% of patients with cirrhosis will develop esophageal varices, which carry with them a 1-year and 3-year bleeding rate of 33% and 41%, respectively. Screening for varices with a video endoscopy is limited by its cost, patient compliance, and the risks of sedating a patient with portal hypertension. Capsule endoscopy is a novel method that may reduce the costs and increase compliance for screening.
The investigators propose to screen 100 consecutive patients with advanced cirrhosis for esophageal varices. A capsule endoscopy and video endoscopy will be done on the same day. The varices seen on video endoscopy will be graded using a standard grading scale. Both capsule and video endoscopy images will be assessed in a blinded fashion by 4 independent investigators. Finally, the video endoscopic images will be compared to capsule endoscopy to develop a capsule endoscopy grading system that corresponds to video endoscopy.
The primary endpoint of the study will be to develop a grading system for esophageal varices using capsule endoscopy. Secondary endpoints of the study include sensitivity, specificity, inter- and intraobserver variation of variceal grading using capsule endoscopy; patient acceptance as assessed on a visual analogue scale; and a cost comparison (facility fees + professional fees) of the two screening methods.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal and Gastric Varices
Keywords
Esophageal Varices, Gastric Varices, Capsule Endoscopy, Portal Hypertension, Cirrhosis, Gastrointestinal Hemorrhage
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Capsule Endoscopy
Arm Type
Experimental
Arm Title
Upper Gastrointestinal Endoscopy
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
Esophageal Capsule Endoscopy
Intervention Type
Device
Intervention Name(s)
Upper Gastrointestinal Endoscopy
Primary Outcome Measure Information:
Title
The primary endpoint of the study will be to develop a grading system for esophageal varices using capsule endoscopy.
Time Frame
Two years
Secondary Outcome Measure Information:
Title
Secondary endpoints include sensitivity, specificity, inter- and intraobserver variation of variceal grading using capsule endoscopy; patient acceptance; and a cost comparison (facility + professional fees) of the two screening methods.
Time Frame
Two years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Advanced cirrhosis with portal hypertension based on imaging, clinical suspicion, or liver biopsy
Age greater than or equal to 18 years old
Able to give consent
Exclusion Criteria:
Current implantable cardioverter-defibrillators or pacemaker in place
Suspected intestinal obstruction
Esophageal swallowing disorder
Esophageal stenosis
Age less than 18 years old
Pregnancy
Known Zenker's diverticulum
Patients with previous endoscopic or surgical esophageal treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul J Thuluvath, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Hospital
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.hopkins-gi.org
Description
Click here for more information about Johns Hopkins Hepatology.
Learn more about this trial
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
We'll reach out to this number within 24 hrs